pharma news

News

Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.

News

Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."

News

Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.

News

Jazz Pharma has dipped its toe into the M&A water again, agreeing to buy rare epilepsy drug developer Actio Bio for $820m upfront.

News

Novo Nordisk has joined forces with Amazon Web Services on a project that will lead to the creation of an AI co-innovation hub in London.

News

Researchers have found that people with early Alzheimer's are not following guidelines for promoting brain health, even if they are on drug therapy.